Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and Pravastatin for Child-Pugh A Hepatocellular Carcinoma
NCT01903694Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Mar 2010
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of pravastatin in hepatocellular carcinoma (HCC), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoint: Overall Survival. Started Mar 2010; status: completed.
02
Drugs
pravastatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01903694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01903694.